A disaccharide exo-cleaving β-mannan hydrolase and its application
Through the disaccharide exototropic β-mannanase Man02066 isolated from bacteria of C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. genus C. and polysaccharide substrate analysis have promoted the development and application of mannanase.
Patent Information
- Application Number
- CN202010525116.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2020-06-10
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2040-06-10
AI Technical Summary
In the prior art, there are few basic research on the substrate selection mechanism, polysaccharide/oligosaccharide degradation mode and oligosaccharide product generation characteristics, resulting in the limitation of the development and application of tool-type mannan exonuclease. , and the in-depth development and directional transformation of enzyme resources lack guiding theories and techniques.
Man02066, a disaccharide exototropic β-mannanase, was obtained from Flammeovirga yaeyamensis, which can degrade polysaccharide substrates such as konjac glucomanan and locust bean gum, with certain thermal stability and narrowness. pH tolerance and catalytic site residues were confirmed through the analysis of its amino acid sequence, laying the foundation for further research and modification of the enzyme.
The specific preparation of mannodisosa is achieved, and the sugar chains can be continuously cleaved from the non-reducing end. It is used to analyze the mole number and even status of polysaccharide substrates. It provides the basis for tool enzymes to study the catalytic mechanism of mannosacid enzymes and is a The transformation and application of enzymes provide guidance.
Smart Images

Figure CN113774042B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biotechnology; in particular, the present invention relates to a disaccharide exo-mannanase and a coding gene and application thereof. Background Art
[0002] Hemicellulose is a structural polysaccharide that constitutes the cell wall of plants. It is usually tightly combined with cellulose and lignin to form lignocellulosic biomass. Among the many types of hemicellulose, mannan and xylan are closely related to people's lives. They are mainly used in industrial fields such as food, medicine, textiles, pulp and paper, and biofuels. Mannan is the second most abundant hemicellulose in nature. It is a type of polysaccharide with a complex structure. According to the different composition structures of sugar units, it can be divided into four categories: pure mannan, glucomannan, galactomannan, and galactoglucomannan.
[0003] In addition to the common feature of mannose units as the main component, the polysaccharide backbone structure of these mannans also has complex characteristics such as random heteropolymerization of multiple sugar units and modularization of local composition, and the side chain structure of mannans also has similar characteristics. Therefore, in order to completely degrade these polysaccharides, the synergistic action of multiple types of enzymes (enzyme systems) is required.
[0004] Compared with chemical or physical methods, the strategy of enzymatic degradation of mannan to prepare oligosaccharides has the advantages of strong controllability due to mild reaction conditions and clear products due to clear substrate selectivity. Therefore, as a tool enzyme for oligosaccharide preparation, mannanase has important research and development value and economic value. At present, β-mannanase has been widely used in various fields such as food, animal husbandry, papermaking, biofuels and oil drilling. In the food industry, β-mannanase, as a feed additive, can act on mannan in food to assist in the production of mannan oligosaccharide prebiotics. In the detergent industry, many types of daily chemical products and foods, such as hair spray, shampoo, conditioner, toothpaste, ice cream and barbecue sauce, contain a certain amount of mannan components as thickeners or stabilizers, and these components are usually difficult to remove once they form stains. If mannan is hydrolyzed by β-mannanase for treatment, it will be transformed from a poorly soluble polysaccharide into a water-soluble oligosaccharide fragment, making it easier to remove stains. In the paper, pulp and paper industry, the use of β-mannanase can promote the removal of lignin in pulp, producing results comparable to alkaline pretreatment and can greatly reduce environmental pollution.
[0005] At present, although there are a large number of patent applications and scientific research literature on β-mannanase, there are relatively few basic studies on the substrate selection mechanism of β-mannanase, the degradation mode of polysaccharide / oligosaccharide substrates, the generation characteristics of oligosaccharide products, and their intrinsic connection with the catalytic mechanism. This deficiency has caused two industry dilemmas: (1) Although a certain number of mannanase products have been industrialized and commercialized, the number and types of tool enzymes that can be accurately applied are extremely scarce; (2) The in-depth development and targeted transformation of enzyme resources lack guiding theories and technical references, which to a certain extent limits the research and development level of tool enzymes.
[0006] In summary, in order to meet the important application needs of tool-type mannan exocarboxylase, it is urgent to carry out comprehensive research and exploration from multiple angles and levels, such as increasing the development of new enzymology resources, strengthening the analysis of the core application value and application characteristics of enzymes, and exploring new guiding theories and technical approaches required for molecular enzymology transformation. Summary of the invention
[0007] In view of the difference from the prior art, the present invention provides a disaccharide exo-acting β-mannan hydrolase Man02066 and its encoding gene and application.
[0008] In a first aspect, the present invention provides an exo-acting β-mannanase, whose amino acid sequence is shown in SEQ ID NO:2.
[0009] In a preferred embodiment, the exo-β-mannanase degrades mannan containing sugar chain branches or linear mannan without sugar chain branches; preferably, the exo-β-mannanase degrades linear mannan without sugar chain branches.
[0010] In a preferred embodiment, the mannan is glucomannan, galactomannan, or pure mannan; preferably pure mannan.
[0011] In a preferred embodiment, the exo-acting β-mannanase can degrade konjac-derived glucomannan (KGM) and locust bean gum-derived galactomannan (LBG); preferably, the polysaccharide substrate of the exo-acting β-mannanase is konjac-derived glucomannan.
[0012] In a preferred embodiment, the exo-acting β-mannanase consists of only one Glycoside hydrolasefamily 26domain module.
[0013] In a preferred embodiment, the reaction temperature for degrading mannan by the exo-acting β-mannanase is 0-40° C. and the pH is 6.0-8.0.
[0014] In a preferred embodiment, the optimum temperature for the exo-acting β-mannanase to degrade konjac glucomannan (KGM) and locust bean gum (LBG) is 40° C., and the optimum pH is 6.0.
[0015] In a preferred embodiment, the exo-acting β-mannanase can also degrade manno-oligosaccharides, the smallest substrate that can be degraded is mannotriose (M3), and the smallest product is mannomonose (M).
[0016] In a second aspect, the present invention provides a nucleotide sequence encoding the exo-β-mannanase described in the first aspect.
[0017] In a specific embodiment, the nucleotide sequence is as shown in SEQ ID NO:1.
[0018] In a third aspect, the present invention provides an expression vector comprising the nucleotide sequence described in the second aspect.
[0019] In a fourth aspect, the present invention provides a host cell, wherein the host cell comprises the expression vector described in the third aspect or the nucleotide sequence described in the second aspect is integrated into its genome.
[0020] In a preferred embodiment, the host cell is a host cell for producing the exo-β-mannanase or for degrading β-mannan.
[0021] In a fifth aspect, the present invention provides use of the exo-acting β-mannanase described in the first aspect in degrading mannan.
[0022] In a preferred embodiment, the mannan contains sugar chain branched mannan or linear mannan without sugar chain branch; preferably, the mannan is linear mannan without sugar chain branch.
[0023] In a preferred embodiment, the mannan is glucomannan, galactomannan, or pure mannan; preferably pure mannan.
[0024] In a sixth aspect, the present invention provides the use of the exo-acting β-mannanase described in the first aspect in analyzing and determining the molar number of sugar chains of its original polysaccharide substrate and determining the parity status of the original substrate.
[0025] In a seventh aspect, the present invention provides an exo-β-mannanase, wherein the exo-β-mannanase is the exo-β-mannanase mutant described in the first aspect.
[0026] In a specific embodiment, the amino acid sequence of the exo-acting β-mannanase is as shown in SEQ ID NO: 2, but a mutation occurs at position 188 and / or 296.
[0027] In a preferred embodiment, the amino acid at position 188 of the amino acid sequence of the exo-β-mannanase is mutated from glutamic acid to alanine, and / or the amino acid at position 296 is mutated from glutamic acid to alanine.
[0028] In an eighth aspect, the present invention provides a mannan degradation product, wherein the degradation product is obtained by degrading mannan using the exo-acting β-mannanase described in the first aspect.
[0029] In a preferred embodiment, the mannan is mannan containing sugar chain branches or linear mannan without sugar chain branches; preferably, the mannan is linear mannan without sugar chain branches.
[0030] In a preferred embodiment, the mannan is glucomannan, galactomannan, or pure mannan; preferably pure mannan.
[0031] In a preferred embodiment, the mannan is konjac-derived glucomannan (KGM) or locust bean gum-derived galactomannan (LBG); preferably, the mannan is konjac-derived glucomannan.
[0032] In a ninth aspect, the present invention also provides the use of the exo-acting β-mannanase and its mutant enzyme as a tool enzyme in studying the catalytic mechanism of mannanase.
[0033] It should be understood that within the scope of the present invention, the above-mentioned technical features of the present invention and the technical features specifically described below (such as embodiments) can be combined with each other to form a new or preferred technical solution. Due to space limitations, they will not be described one by one here. BRIEF DESCRIPTION OF THE DRAWINGS
[0034] Figure 1 This is the result of the analysis of the functional module composition of the exo-β-mannanase Man02066;
[0035] Figure 2 The polyacrylamide gel electrophoresis diagram of the expression and purification of the recombinant exo-β-mannanase rMan02066; in the figure: M, protein molecular weight standard, the band sizes from top to bottom are 116kDa, 66.2kDa, 45kDa, 35kDa, 25kDa, 18.4kDa, 14.4kDa; Lane 1, control strain before cell wall breaking, sample volume 10μL; Lane 2, recombinant bacteria before cell wall breaking, sample volume 2μL; Lane 3, recombinant bacteria after cell wall breaking supernatant, sample volume 2μL; Lane 4, rMan02066 purified by nickel column, sample volume 2μL;
[0036] Figure 3The curve diagram shows the effect of temperature on the degradation activity of konjac glucomannan (A) and locust bean gum (B) by recombinant β-mannanase rMan02066;
[0037] Figure 4 The curve diagram shows the effect of pH on the stability of konjac glucomannan (A) and locust bean gum (B) degraded by recombinant β-mannanase rMan02066;
[0038] Figure 5 The curve diagram shows the effect of temperature on the stability of konjac glucomannan (A) and locust bean gum (B) degraded by recombinant β-mannanase rMan02066;
[0039] Figure 6 The curve diagram shows the effect of pH value on the activity and stability of recombinant β-mannanase rMan02066 in degrading konjac glucomannan (A) and locust bean gum (B);
[0040] Figure 7 The bar graph shows the effects of metal ions and chemical reagents on the degradation of konjac glucomannan (A) and locust bean gum (B) by recombinant β-mannanase rMan02066;
[0041] Figure 8 TLC analysis of oligosaccharide products during the degradation of konjac glucomannan (A) and locust bean gum (B) by recombinant β-mannanase rMan02066; Figure A: M in the horizontal axis, mannose-mannohexaose; 1, control; 2-10, respectively represent: 10s, 1min, 10min, 1h, 4h, 6h, 24h, 48h, 72h; Figure B: M in the horizontal axis, mannose-mannohexaose; 1, control; 2-9, respectively represent: 10s, 1min, 10min, 1h, 6h, 24h, 48h, 72h;
[0042] Fig. 9 Oligosaccharide fragments prepared by complete degradation of konjac glucomannan (A) and locust bean gum (B) by recombinant β-mannanase rMan02066 1 H-NMR spectrum;
[0043] Fig.10The figure is a TLC analysis diagram of oligosaccharide products of a series of manno-oligosaccharides (M-M6) completely degraded by recombinant β-mannanase rMan02066; wherein Figure A: In the horizontal axis: A: Sample order: M: M1-M6; 1: M1(-); 2: M1(+); 3: M2(-); 4: M2(+); 5: M3(-); 6: M3(+); 7: M4(-); 8: M4(+); 9: M5(-); 10: M5(+); 11: M6(-); 12: M7(+); 13: M8(-); 14: M9(+); 15: M10(-); 16: M11(+); 17: M12(-); 18: M13(+); 19: M14(-); 20: M15(+); 21: M16(-); 22: M17(+); 23: M18(-); 24: M19(+); 25: M20(-); 26: M21(+); 27: M2 1: M6(-); 12: M6(+); (-) is the negative control group, (+) is the experimental group; Figure B: In the horizontal axis: M, M1-M6; 1: control; 2: enzyme solution diluted 10 times and reacted for 10s; 3-8: 10s, 1min, 30min, 3h, 12h, 48h; Figure C: In the horizontal axis: M, M1-M6; 1, control; 2, enzyme solution diluted 10 times and reacted for 10s; 3-5, 10s, 1min, 48h;
[0044] Fig.11 Analysis of the final main product of degradation of 2AB-labeled manno-oligosaccharides of a series of sizes (2AB-M to 2AB-M6) by recombinant β-mannanase rMan02066 (A), HPLC analysis of oligosaccharide products of degradation of 2AB-labeled mannopentaose (2AB-M5) (B) and 2AB-labeled mannohexaose (2AB-M6) (C) at different reaction times (fluorescence);
[0045] Fig.12 It is the multiple sequence alignment of β-mannanase Man02066 and GH26 family β-mannanase;
[0046] Fig.13 Relative activity analysis of β-mannanase Man02066 mutant in degrading konjac glucomannan (A) and locust bean gum (B), respectively. DETAILED DESCRIPTION
[0047] After extensive and in-depth research, the inventor unexpectedly obtained a disaccharide exo-acting β-mannanase Man02066 from the bacterium Flammeovirgayaeyamensis MY04; the enzyme can degrade konjac glucomannan as well as other polysaccharide substrates such as locust bean gum, and has a certain thermal stability (0-40°C), so it can be used for the specific preparation of mannobiose. On this basis, the present invention was completed.
[0048] All scientific or technical terms used herein have the conventional meanings understood by those of ordinary skill in the art to which the present invention belongs. For the sake of clarity, some of the terms or concepts used herein are defined or explained as follows. However, the following definitions or explanations are provided only to help technicians better understand the essence of the present invention and are not intended to indicate the scope of protection of the present invention in any way.
[0049] β-Mannanase
[0050] The "β-mannanase" used herein has the meaning commonly understood by those skilled in the art, and refers to a class of hydrolases that can hydrolyze manno-oligosaccharides and mannopolysaccharides (including mannan, glucomannan, galactomannan and galactoglucomannan) containing β-1,4 mannosidic bonds.
[0051] According to the characteristics of the enzyme's substrate selectivity and catalytic mode, β-mannanase can be divided into endo-type β-mannanase (EC 3.2.1.78) and exo-type β-mannanase (EC 3.2.1.100). Among them, endo-type β-mannanase can hydrolyze the β-1,4 glycosidic bonds inside the main chain of mannan to produce a series of manno-oligosaccharide fragments with different polymerization degrees; while exo-type β-mannanase acts continuously on the β-1,4 glycosidic bonds in the substrate sugar chain from the end of the non-reducing chain, cutting and producing fixed-size sugar unit products, such as mannobiose. β-Mannanase is widely present in natural organisms, including animals, plants and microorganisms. In-depth research shows that microorganisms are the main source of β-mannanase production, especially bacteria, fungi and actinomycetes. In contrast, there are fewer β-mannanases from animals and plants, which are mainly distributed in the seeds of leguminous plants and the digestive juices of mollusks.
[0052] At present, the research on exomannanase at home and abroad is generally weak. Compared with endoenzymes, the number of scientific research papers or patent applications is relatively small. In addition: (1) To date, there are dozens or even hundreds of endomannan hydrolases reported in the literature, which are mainly classified into the glycosyl hydrolase family GH5, GH26, GH113 or GH34 family included in the Carbohydrate Active Enzyme Database (CAZy, http: / / www.cazy.org / ), while there are only a few exomannanases, which are classified into the GH26 family. Among the members of the GH26 family, only two exomannan hydrolases have been systematically identified, including BfMan26A from Bacteroides fragilis NCTC 9343 (K. Kawaguchi, T. Senoura, S. Ito, T. Taira, H. Ito, J. Wasaki, S. Ito, The mannobiose-forming exo-mannanase involved in a new mannan catabolic pathway in Bacteroides fragilis, Arch. Microbiol. 196 (2014) 17-23) and CjMan26C from Cellvibrio japonicus Ueda107 (K. Kawaguchi, T. Senoura, S. Ito, T. Taira, H. Ito, J. Wasaki, S. Ito, The mannobiose-forming exo-mannanase involved in a new mannan catabolic pathway in Bacteroides fragilis, Arch. Microbiol. 196 (2014) 17-23).In contrast, the majority of GH26 family members are still endo-mannan hydrolases, such as CjMan26A of Cellvibrio japonicus Ueda107 (Ducros, V., Zechel, DL, Murshudov, G., Gilbert, HJ, Szabo, L., Stoll, D., Withers, SG, Davies, GJ (2002) Angew Chem Int Ed Engl 41:2824), BoMan26B of Bacteroides ovatus (Bagenholm, V., Wiemann, M., Reddy, SK, Bhattacharya, A., Rosengren, A., Logan, DT, Stalbrand, H. (2019) J Biol Chem 294:9100-9117), and there are also a few with unclear catalytic modes, such as GH26i of uncultured Bacteroidetes bacterium (Mackenzie AK, Naas AE, Kracun SK, et al. A polysaccharide utilization locus from an uncultured bacteroidetes phylotype suggests ecological adaptation and substrate versatility. Appl Environ Microbiol. 2015; 81(1): 187-195). Therefore, in order to obtain more tool enzymes, it is urgent to increase the exploration of new resources of exomannanase. (2) Secondly, analyzing the literature on exomannanase (EC3.2.1.100) included in the GH26 family, it is currently known that only BfMan26A and CjMan26C strictly continuously cleave disaccharide units from the non-reducing end of the substrate sugar chain to completely degrade mannan, and the final oligosaccharide main product is mainly disaccharides, so they are both typical disaccharide exomannan hydrolases. In contrast, BoMan26A of Bacteroides ovatus can cleave disaccharide or trisaccharide units from the non-reducing end of the substrate sugar chain, and mannobiose is the main product (. V, Reddy SK, Bouraoui H, et al. Galactomannan Catabolism Conferred by a Polysaccharide Utilization Locus of Bacteroides ovatus ENZYME SYNERGY AND CRYSTAL STRUCTURE OF A β-MANNANASE [J]. Journal of Biological Chemistry, 2017, 292 (1): 229-243). However, from the analysis of the two catalytic characteristics of substrate degradation mode and oligosaccharide generation characteristics, BoMan26A does not belong to the strict disaccharide exo-type mannanase, and referring to the research results of the inventors of this patent application on the endonuclease Man01929, it is speculated that BoMan26A should be a typical endo-type mannohydrolase with a variable substrate degradation mode. In addition, the study of the polysaccharide degradation pattern of RsMan26H from Reticulitermes speratus also found that in a short period of time (10 minutes), oligosaccharides with high polymerization degree (DP5-DP20) were mainly produced, and as time (10-30 minutes) prolonged, mannopentaose and mannohexaose continued to accumulate, and finally (after 30 minutes of reaction) mannotriose, mannobiose, and mannose continued to accumulate. Therefore, the literature reported RsMan26H as an endo-mannanase (Tsukagoshi H, Nakamura A, Ishida T, et al. The GH26 β-mannanase RsMan26H from a symbiotic protist of the termite Reticulitermes speratus is an endo-processive mannobiohydrolase: heterologous expression and characterization. Biochem Biophys Res Commun. 2014; 452(3): 520-525). The literature has not provided clear conclusions on the catalytic mode and oligosaccharide production characteristics of GH26i from uncultured Bacteroidetes bacteria. Therefore, in order to obtain tools, it is necessary to strengthen the analysis and interpretation of the core application value and characteristics of enzymes, such as the enzyme's substrate degradation mode and oligosaccharide production characteristics.(3) The common feature of the five mannan hydrolases in the GH26 family mentioned above is that they can specifically recognize the glycosidic bond within mannose-mannose (MM). However, whether their recognition, binding and degradation of substrates will be affected by galactosyl modification and the specific contribution of key active site residues remain to be further studied.
[0053] β-Mannanase of the present invention
[0054] As used herein, the terms "exo-β-mannanase of the present invention", "β-mannanase of the present invention", "β-mannan hydrolase of the present invention", "β-mannanase Man02066", "β-mannan hydrolase Man02066" and the like have the same meaning.
[0055] In a specific embodiment, the amino acid sequence of the exo-β-mannanase of the present invention is shown in SEQ ID NO: 2. The exo-β-mannanase of the present invention can degrade mannan containing sugar chain branches, and can also degrade linear mannan without sugar chain branches; however, linear mannan without sugar chain branches is the best substrate for the exo-β-mannanase of the present invention.
[0056] The exo-β-mannanase of the present invention has a certain temperature tolerance, and the reaction temperature for degrading mannan is 0-40°C, preferably 20-40°C; in addition, the pH condition for degrading mannan by the exo-β-mannanase of the present invention is 6.0-8.0.
[0057] In a specific embodiment, the optimal temperature for the exo-acting β-mannanase of the present invention to degrade konjac glucomannan (KGM) and locust bean gum (LBG) is 40° C., and the optimal pH is 6.0.
[0058] When degrading mannan substrate, the exo-acting β-mannanase of the present invention can continuously cut the sugar chain from the non-reducing end to the end with mannobiose as the unit, and thus can be used for the specific preparation of mannobiose.
[0059] The exo-acting β-mannanase of the present invention can also be used to analyze and determine the molar number of sugar chains of its original polysaccharide substrate and to judge the parity status of the original substrate.
[0060] On the basis of the exo-acting β-mannanase of the present invention, the inventors further discovered the conserved catalytic site of the exo-acting β-mannanase, thus laying a foundation for further modifying the enzyme.
[0061] In a specific embodiment, the conserved catalytic sites of the exo-β-mannanase of the present invention are at positions 188 and 296.
[0062] In a preferred embodiment, the 188th amino acid in the amino acid sequence of the exo-β-mannanase is mutated from glutamic acid to alanine, and / or the 296th amino acid is mutated from glutamic acid to alanine to obtain an inactive mutant. Therefore, the exo-β-mannanase and its mutant enzyme of the present invention can be used as a tool enzyme to study the catalytic mechanism of mannanase.
[0063] Beneficial effects of the present invention
[0064] 1. The present invention discloses for the first time that a disaccharide exo-acting β-mannanase Man02066 is obtained from Flammeovirga yaeyamensis MY04;
[0065] 2. The enzyme Man02066 can degrade not only konjac glucomannan, but also other polysaccharide substrates such as locust bean gum;
[0066] 3. The enzyme has a certain degree of thermal stability (0-40°C) and a narrow pH tolerance (6.0-8.0);
[0067] 3. When the enzyme degrades a series of pure manno-oligosaccharide substrates or pure manno-oligosaccharide substrates with fluorescent labels at the reducing end, it continuously cuts the sugar chain from the non-reducing end to the end, taking mannobiose as the unit, so it can be used for the specific preparation of mannobiose;
[0068] 4. The present invention confirms that the catalytic site residues of the enzyme are Glu188 (acid / base catalysis) and Glu296 (nucleophilic catalysis), thus laying a foundation for the study of exo-type β-mannanase;
[0069] 5. When the enzyme degrades a series of manno-oligosaccharide substrates labeled with o-aminobenzamide at the reducing end, it can continuously cut M2 sugar from the non-reducing end until the remaining mannobiose (2AB-M2) or mannose (2AB-M), and when the final product is 2AB-M2, the corresponding original substrate is an even-numbered sugar chain, and the molar number is equal to it; and when the final product is 2AB-M1, the corresponding original substrate is an odd-numbered sugar chain, and the molar number is equal to it. Therefore, in theory, the enzyme or its recombinant enzyme, combined with the fluorescent labeling and analysis of the sugar chain substrate, can be used to analyze and determine the molar number of the sugar chain of its original polysaccharide substrate, that is, used as a molar counter of the polysaccharide substrate, and can also determine the odd-even status of the original substrate.
[0070] The present invention will be further described below in conjunction with specific examples. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. The experimental methods in the following examples without specifying specific conditions are usually based on conventional conditions or the conditions recommended by the manufacturer. Unless otherwise stated, percentages and parts are calculated by weight.
[0071] Example
[0072] Source of experimental materials
[0073] The Flammeovirga yaeyamensis MY04 strain was obtained from the General Microbiology Center of China Culture Collection Administration, address: Institute of Microbiology, Chinese Academy of Sciences, No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing, deposited on November 27, 2008, with deposit number CGMCC NO.2777.
[0074] In the following examples, it is referred to as Chromobacterium firebacterium MY04.
[0075] The experimental materials involved in the examples without giving specific sources are all common commercially available products.
[0076] Example 1. Extraction of genomic DNA from Chromobacterium pyrochromogenes MY04 strain
[0077] The bacillus MY04 was inoculated into the liquid medium YT04 and cultured under the conditions of 28°C and 200 rpm with shaking until the absorbance at 600 nm (OD 600 ) is 1.2; take 10 mL of the culture solution, centrifuge it at 12,000×g, 4℃ for 15 min, and collect the bacterial precipitate; suspend the bacteria in 10 mL of lysozyme buffer (10 mM Tris-HCl, pH 8.0), centrifuge it at 12,000×g, 4℃ for 15 min, and collect the bacterial precipitate.
[0078] The above liquid culture medium YT04 has the following components per liter:
[0079] Tryptone 10g, yeast extract 5.0g, sodium chloride 30g, dissolved in water and adjusted to 1L, pH 7.2.
[0080] To the above bacterial precipitate, 6.0 mL of lysozyme buffer was added to each tube to obtain about 7.0 mL of bacterial solution, and 280 μL of lysozyme solution with a concentration of 20 mg / mL was added to each tube to make the final concentration of lysozyme 800 μg / mL; placed in an ice water bath for 1.0 h, then transferred to a 37°C water bath and incubated for 2 h until the reaction system became viscous; 0.41 mL of sodium hexadecyl sulfate solution with a concentration of 100 mg / mL and 30 μL of proteinase K solution with a concentration of 100 mg / mL were added, and incubated at 52°C for 1.0 h; 7.5 mL of Tris-equilibrated phenol / chloroform / isoamyl alcohol (volume ratio 25:24:1) solution was added, and the mixture was gently inverted to mix; centrifuged at 10,000×g and 4°C for 10 min, the supernatant was collected, and 1.0 mL of NaAc-HAc (pH 5.2, 3.0M) buffer, and 8.5mL of anhydrous ethanol, mix thoroughly; pick out the filamentous DNA with a pipette tip, transfer it to a 1.5mL centrifuge tube, wash it twice with 70% ethanol (stored at -20°C), discard the supernatant after microcentrifugation; centrifuge at 10,000×g, 4°C for 2min, and completely discard the supernatant; blow dry the DNA precipitate on a sterile workbench, and then dissolve the DNA sample with sterile deionized water at 4°C overnight to obtain genomic DNA.
[0081] Example 2. Scanning and sequence analysis of the genome of Chromobacterium pyrochromogenes MY04 strain
[0082] The inventors found a β-mannanase encoding gene man02066 in the genomic DNA of the fire bacillus MY04 strain obtained in Example 1. The coding region of the gene man02066 is 1137 bp long, and the nucleotide sequence is shown in SEQ ID NO: 1. The β-mannanase Man02066 encoded by the gene man02066 contains a total of 378 amino acids, and its amino acid sequence is shown in SEQ ID NO: 2.
[0083] Example 3. Recombinant expression of gene man02066 in Escherichia coli BL21 (DE3) strain
[0084] The genomic DNA prepared in Example 1 was used as a template for PCR amplification. The primer sequences are as follows:
[0085] Forward primer for man02066 amplification
[0086] Man02066-F:5'-gcg CATATG GAAGATAAGGCAAAGACACC-3' (SEQ ID NO: 3);
[0087] Reverse primer for man02066 amplification
[0088] Man02066-F:5'-gcg CTCGAG ATTCACTTTCATATTCATCAAATC-3' (SEQ ID NO: 4);
[0089] The underlined site of the forward primer is the specific site of the restriction endonuclease Nde I, and the underlined site of the reverse primer is the specific site of the restriction endonuclease Xho I.
[0090] The high-fidelity DNA polymerase Prime STAR HS DNA Polymerase used was purchased from Dalian Takara Biotechnology Co., Ltd., China, and the PCR reaction reagents used were operated according to the product instructions provided by the company.
[0091] PCR reaction system:
[0092] 2×Primer star GC buffer 5μL, forward primer for amplification 0.35μL, reverse primer for amplification 0.35μL, Template (1ng / μL) 1μL, ddH2O 3.3μL, polymerase 0.1μL, dNTP 0.8μL.
[0093] PCR reaction conditions:
[0094] Pre-denaturation at 95°C for 4 min; denaturation at 94°C for 40 s, annealing at 60°C for 30 s, extension at 72°C for 90 s, 35 cycles; extension at 72°C for 10 min; stabilization at 4°C for 10 min.
[0095] The PCR product was double digested with restriction endonucleases Nde I and Xho I, and the PCR product after digestion was recovered by agarose gel electrophoresis. The pET-30a (+) plasmid DNA purchased from Invitrogen, USA, was double digested with Nde I and Xho I, and agarose gel electrophoresis was performed to recover the product fragments after digestion. Restriction endonucleases Nde I and Xho I were purchased from Dalian Bao Biotechnology Co., Ltd., China, and the enzyme and substrate reaction system, temperature and time used for digestion were operated according to the product instructions provided by the company.
[0096] The PCR product double-digested with Nde I and Xho I was ligated with the pET-30a(+) plasmid vector double-digested with the same enzymes under the catalysis of DNA ligase; the ligation product was transformed into the Escherichia coli DH5α strain, spread on a solid plate of Luria-Bertani medium containing 50 μg / mL kanamycin, and cultured at 37°C for 16 hours, and then a single clone was picked; the single clone was inoculated into a liquid Luria-Bertani medium containing 50 μg / mL kanamycin for culture, and the plasmid DNA was isolated and purified; the plasmid was verified by PCR using amplification primers, and the result was an amplification product of 2.8 kb in size, which preliminarily proved that the constructed recombinant plasmid was correct; then the recombinant plasmid was sequenced, and the results showed that the gene man02066 shown in SEQID NO.1 was inserted between the Nde I and Xho I restriction sites of pET-30a(+), and the insertion direction was correct, thereby further proving that the constructed recombinant plasmid was correct.
[0097] The correct recombinant plasmid was named pE30a-Man02066, and transformed into Escherichia coli strain BL21 (DE3) (purchased from Invitrogen, USA). Then, according to the operation steps provided by Invitrogen, the recombinant β-mannanase Man02066 was induced to express with a final concentration of 0.05 mM isopropylthiogalactoside (IPTG); centrifuged at 8,000 × g and 4 ° C for 15 min, the bacteria were collected, and the bacteria were resuspended with buffer A and ultrasonically broken in an ice water bath. Further centrifuged at 15,000 × g and 4 ° C for 30 min, the water-soluble components were collected, and the recombinant β-mannanase rMan02066 was adsorbed separately with Ni-agarose gel. Gradient elution was performed with buffer A containing imidazole concentrations of 10, 50, 100, 250, and 500 mM, and the purification conditions were operated according to the product manual of the gel. The purification of recombinant β-mannanase rMan02066 was detected by polyacrylamide gel electrophoresis. Figure 2 As shown: after the recombinant plasmid pE30a-Man02066 was expressed in E. coli BL21 (DE3) strain by IPTG induction, the product was expressed in water-soluble form, and the recombinant enzyme rMan02066 purified by nickel column affinity chromatography showed a single band on the electrophoresis gel, and the position was consistent with the predicted molecular weight; the purified recombinant enzyme rMan02066 sample was placed in a dialysis bag with a minimum molecular cutoff of 8-14 kDa, and dialyzed against buffer A at 4°C. The components of the buffer A were 50 mM Tris, 150 mM NaCl, pH 8.0, and the recombinant β-mannanase rMan02066 enzyme solution was obtained.
[0098] Example 4. Determination of the optimal temperature of the recombinant enzyme β-mannanase rMan02066
[0099] Konjac glucomannan and locust bean gum were prepared with deionized water at a mass volume concentration of 0.3% (w / v), heated and dissolved, and then placed in a water bath environment at 0°C, 10°C, 20°C, 30°C, 35°C, 40°C, 45°C, 50°C, 60°C, 70°C, and 80°C for 1 hour. 100 μL of the dilution of the recombinant β-mannanase rMan02066 prepared in Example 3 was added to each 900 μL substrate solution, wherein the dilution concentration of the recombinant β-mannanase rMan02066 was 10 μg / mL, mixed and continued to react, and samples were taken at intervals. Three parallel samples were prepared under each temperature condition, and the recombinant enzyme preparation inactivated in a boiling water bath was used as the control group.
[0100] The concentration of newly generated reducing sugar in each reaction system was determined by DNS-reducing sugar method (OD 540 ), and calculate the average value for deviation analysis. The reaction temperature corresponding to the maximum absorption value is the optimal temperature of the recombinant enzyme, and the relative enzyme activity (RA) is defined as the percentage of each absorption value to the maximum absorption value. Figure 3 As shown: when the enzyme activity was measured using konjac glucomannan (KGM) and locust bean gum (LBG) of equal mass volume concentration as described above as substrates, the recombinant β-mannanase Man02066 reached maximum activity when degrading KGM and LBG at 40°C, indicating that the optimal reaction temperature for the enzyme to degrade KGM and LBG was the same, both at 40°C.
[0101] Example 5. Determination of the optimal pH of recombinant β-mannanase rMan02066
[0102] Konjac glucomannan or locust bean gum substrates with a mass volume concentration (g / mL) of 0.3% were prepared with 50mM NaAc-HAC buffer, 50mM NaH2PO4-Na2HPO4 buffer, and 50mM Tris-HCl buffer, respectively, and the corresponding pH values were (5, 6), (6, 7, 8), and (7, 8, 9, 10) sections, and the enzyme activity was measured at the optimum temperature for each pH value. Each substrate was incubated at the optimum temperature for 1 hour, and then 100μL of the dilution of the recombinant β-mannanase rMan02066 prepared in Example 3 was added to each 900μL substrate. After mixing, the reaction was started and samples were taken at intervals. Three parallel samples were prepared under each pH condition, and the recombinant enzyme preparation inactivated in a boiling water bath was used as the control group. The DNS-reducing sugar method was used to determine the newly generated reducing sugar concentration (OD 540), and the mean and deviation were calculated. Relative enzyme (RA) activity was defined as the percentage of the average absorption value of each group to the maximum absorption value. The pH corresponding to the maximum absorption value was the optimal pH of the recombinant enzyme. Figure 4 As shown: The optimal reaction pH for the enzyme to degrade KGM and LBG is 6.0.
[0103] Example 6. Temperature stability analysis of recombinant β-mannanase rMan02066
[0104] The recombinant β-mannanase rMan02066 enzyme solution prepared in Example 3 after heat treatment at 0°C, 10°C, 20°C, 30°C, 40°C, 50°C, 60°C, 70°C, and 80°C for different time periods was mixed with konjac glucomannan or locust bean gum having a mass volume concentration (g / mL) of 0.3% prepared with distilled water at a ratio of 1:9 (volume ratio), and then the residual enzyme activity was measured at the optimal temperature, and the enzyme activity of the enzyme solution without heat treatment was defined as 100% relative activity. The results are shown in FIG. Figure 5 As shown: after the recombinant enzyme rMan02066 was incubated at 0-40℃ for 24h, the residual activity was greater than 75% when degrading KGM; and the residual activity was greater than 60% when degrading LBG. The above results show that β-mannanase Man02066 is relatively stable at 0-40℃.
[0105] Example 7. pH stability analysis of recombinant β-mannanase rMan02066
[0106] The enzyme solution of the recombinant β-mannanase rMan02066 prepared in Example 3 was pre-incubated for 2 h in an ice-water bath and different pH (pH 5-10) environments, and then mixed with a konjac glucomannan or locust bean gum substrate solution with a mass volume concentration (g / mL) of 0.3% and pretreated for 1 h at the optimal temperature at a ratio of 1:9 (volume ratio), and then the residual enzyme activity was measured at the optimal temperature, and the enzyme activity of the enzyme solution without pretreatment was defined as 100%, and the relative activity was calculated. The results are as follows Figure 6 As shown: After the recombinant enzyme rMan02066 was pretreated in a buffer solution of pH 5.0-10.0 for 2 hours, whether it was degrading glucomannan (KGM) or locust bean gum (LBG), when the pH was less than 6.0 or greater than 8.0, the residual activity of the recombinant enzyme rMan02066 decreased sharply. The above results show that β-mannanase Man02066 is not resistant to acid-base changes and is easily inactivated.
[0107] Example 8. Effects of metal ions and chemical reagents on the activity of recombinant β-mannanase rMan02066
[0108] After mixing 0.3% konjac glucomannan or locust bean gum substrate prepared with deionized water, the recombinant β-mannanase rMan02066 prepared in Example 3, and water in a ratio of 5:1:4 (volume ratio), different metal ions were added to the reaction system, and the final concentration of the added ions was 1mM or 10mM. Then, the reaction was carried out under the optimal conditions, and the enzyme activity was measured according to the DNS-reducing sugar method mentioned above. The control group was the activity of rMan02066 without adding any metal ions (set to 100%). The results are as follows Figure 7 As shown in the figure: When the recombinant enzyme rMan02066 degraded KGM, (1) 10 mM Ag+ could significantly inhibit the activity of the recombinant enzyme rMan02066, with the relative enzyme activity being only 7%; (2) in addition to Ca 2+ Mg 2+ , Mn 2+ There is also 1mM Co 2+ , Fe 2+ Except for 10 mM EDTA, the other divalent and trivalent metal ions can inactivate the recombinant enzyme rMan02066; (3) 10 mM EDTA and 1 mM or 10 mM SDS can significantly inhibit the activity of the recombinant enzyme rMan02066 or even inactivate it. The difference between the enzyme and KGM in degrading LBG is that: (1) 10 mM K + It can significantly inhibit the activity of the recombinase rMan02066; (2) Co 2+ It can inactivate the recombinase rMan02066; (3) 10mM DTT can significantly inhibit the activity of the recombinase rMan02066.
[0109] Example 9. DNS-reducing sugar method to determine the enzyme activity of recombinant β-mannanase rMan02066
[0110] Konjac glucomannan, locust bean gum, and guar gum substrates with a mass concentration of 0.3% prepared with deionized water, recombinant β-mannanase rMan02066 enzyme solution with a concentration of 10 μg / mL, optimal buffer and water were mixed in a ratio of 2:1:3:4 (volume ratio) and reacted at the optimal temperature. The reaction product was heated in a boiling water bath for 10 minutes, transferred to an ice water bath for 5 minutes, centrifuged at 12,000×g and 4°C for 15 minutes, and the supernatant was collected; a certain volume of supernatant was mixed with an equal volume of DNS (3,5-paranitroxylene)-reaction solution, heated in a boiling water bath for 10 minutes, cooled to room temperature, and the absorption value was measured at 540nm. Using analytically pure mannose as a standard, the same method was used to plot the molar concentration of mannose and OD 540The dose-effect curve between them. The protein content in the recombinant β-mannanase rMan02066 enzyme solution was determined using a protein quantification kit purchased from Shanghai Shenggong Bioengineering Co., Ltd. The activity unit of the enzyme was calculated according to the international standard definition, that is, under standard conditions, the amount of enzyme required to produce 1 μmol of product per minute is 1 IU. The results showed that the recombinant β-mannanase rMan02066 can use konjac glucomannan or locust bean gum as substrates, enzymatically hydrolyze and produce reducing sugar products, and the enzyme activities are 30.67±1.2U / mg and 12.44±1.5U / mg, respectively, but the enzyme can hardly degrade the guar gum polysaccharide used in the test.
[0111] Example 10. TLC analysis of oligosaccharide products from degradation of konjac glucomannan and locust bean gum by recombinant β-mannanase rMan02066
[0112] Prepare konjac glucomannan and locust bean gum substrates with a mass volume concentration (g / mL) of 0.3% with deionized water, heat and dissolve, and place in a 40℃ and 50℃ water bath environment to cool for 1h. Add 1-100μL of the dilution of the recombinant enzyme rMan02066 prepared in Example 3 to each 100μL substrate. If the volume is less than 200μL, add sterile deionized water; continue the reaction after mixing, and take samples at intervals. Heat the reaction product in a boiling water bath for 10min, transfer to an ice water bath and place for 5min; centrifuge at 12,000×g and 4℃ for 15min, and collect the supernatant. The recombinant β-mannan rMan02066 enzyme solution inactivated in a boiling water bath in advance is used as a negative control reaction.
[0113] The product was analyzed by thin layer chromatography (TLC). 4uL of the supernatant was taken onto a chromatography plate (TLC Silica 60 F254, MERK, Germany). The developing solvent was n-butanol: ethanol: water in a volume ratio of 2:1:1, and the color developer was diphenylamine: aniline: phosphoric acid: acetone = 1g: 1mL: 5mL: 50mL. The product was stained for 10s, then developed at 110°C for 10min and photographed.
[0114] Figure 8 It is the TLC analysis diagram of oligosaccharide products in the process of degradation of konjac glucomannan (A) and locust bean gum (B) by recombinant β-mannanase rMan02066;
[0115] In Figure A, M in the horizontal axis is mannose-mannohexose; 1 is control; 2-10 represent: 10s, 1min, 10min, 1h, 4h, 6h, 24h, 48h, 72h, respectively;
[0116] Figure B: In the horizontal axis, M represents mannose-mannohexose; 1 represents control; 2-9 represent: 10s, 1min, 10min, 1h, 6h, 24h, 48h, 72h, respectively.
[0117] The results are as follows Figure 8 As shown in (A), when the recombinant enzyme rMan02066 degrades KGM, a series of oligosaccharides are generated in a short period of time. After 48 hours, the oligosaccharides are mainly tetrasaccharides to disaccharides. Figure 8 As shown in (B), when the recombinant enzyme rMan02066 degraded LBG, there was a large difference, that is, the main oligosaccharide product was disaccharide in a short time, and as time went on, the disaccharide products gradually accumulated, and finally disaccharide was significantly dominant. After comprehensive analysis, it was preliminarily speculated that when the recombinant enzyme rMan02066 degraded KGM, it was a disaccharide exo-cleavage mode, but due to the low activity of rMan02066 on KGM and the presence of glucose units in the main chain structure of KGM, a series of oligosaccharide products of different sizes were produced during the enzymatic hydrolysis, and the oligosaccharide products when the recombinant enzyme rMan02066 degraded LBG had certain differences in TLC analysis. Therefore, when the recombinant enzyme rMan02066 degraded different mannan substrates such as KGM and LBG, the composition and structure of the substrate, the enzyme cleavage speed, etc. would cause different substrate degradation behaviors.
[0118] Example 11. Complete degradation of oligosaccharide products of konjac glucomannan and locust bean gum by recombinant β-mannanase rMan02066 1 H-NMR identification
[0119] Recombinant β-mannanase rMan02066 was used to completely degrade glucomannan and locust bean gum, and the enzymatic products were concentrated. The samples were separated and purified by high performance liquid gel chromatography. The detector was a differential refractive index detector (RID), and the chromatographic column was Superdex TM 30Increase 10 / 300GL, the mobile phase was 0.2 M ammonium bicarbonate, and the flow rate was 0.4 mL / min.
[0120] The separated and purified samples were freeze-dried and desalted multiple times, then dissolved in heavy water (D2O), freeze-dried for hydrogen-deuterium replacement, and finally 1 H-NMR detection.
[0121] pass 1 H-NMR data analysis of the degradation of konjac glucomannan by the recombinant β-mannanase rMan02066 Fig. 9 A) and locust bean gum ( Fig. 9 B) Structural characteristics of the oligosaccharide products.
[0122] The final main product of KGM degradation by recombinant enzyme rMan02066 was separated by molecular gel chromatography to obtain disaccharide, trisaccharide and tetrasaccharide product fragments, respectively. 1 H-NMR structural identification, such as Fig. 9 As shown in (A), the chemical shift values of 5.26 ppm and 5.04 ppm correspond to the anomeric hydrogen signals of glucose and mannose at the reducing end of the oligosaccharide, respectively. From the above results, it is inferred that the recombinant enzyme rMan02066 is similar to rMan01929, and tends to produce a series of oligosaccharide final product fragments with mannose as the main reducing end after degrading KGM.
[0123] The final main product of LBG degradation by recombinant enzyme rMan02066 was separated to obtain oligosaccharide fragments such as disaccharide to tetrasaccharide, hexasaccharide to octasaccharide, but no pentasaccharide product fragment was obtained. 1 H-NMR test, the results are as follows Fig. 9 As shown in (B), after the same analysis, it is believed that: (1) the main product disaccharide fragment in the enzymatic hydrolysis reaction is mainly MM, containing a small amount of MG (G is galactose); (2) in the enzymatic hydrolysis of LBG, the galactose content in the larger oligosaccharide product fragments is higher, which inhibits the further degradation of these products by the recombinant enzyme rMan02066. This shows that in the process of Man02066 degrading LBG, the disaccharide product MM is actively generated, while the higher molecular weight oligosaccharide products are rich in galactose, which is not conducive to further deep enzymatic degradation and passively becomes a component of the final main product of oligosaccharides.
[0124] Example 12. Analysis of the final products of a series of manno-oligosaccharide degradation by recombinant enzyme rMan02066
[0125] Take a solution containing about 20 μg of a series of manno-oligosaccharides (M-M6), a 150 mmol / L NaH2PO4-Na2HPO4 (pH 7.0) buffer solution, and a dilution of the recombinant β-mannanase rMan02066 prepared in Example 3, mix them in a volume ratio of 1:1:1, and react at 40°C for 24 hours. Place the reaction system in a boiling water bath for 10 minutes, transfer to an ice water bath for 5 minutes, and centrifuge at 12,000×g and 4°C for at least 15 minutes. Collect the supernatant as the oligosaccharide degradation product of the recombinant β-mannanase rMan02066. Use the recombinant β-mannanase rMan02066 enzyme solution inactivated in a boiling water bath in advance as a negative control reaction.
[0126] According to the development conditions described in Example 10, the sample of manno-oligosaccharide (M-M6) was hydrolyzed by recombinant β-mannanase rMan02066, and 2 uL was taken for detection. According to the color development conditions described in Example 10, color development was performed and then analyzed.
[0127] Fig.10It is a TLC analysis chart of oligosaccharide products of a series of manno-oligosaccharides (M-M6) completely degraded by recombinant β-mannanase rMan02066;
[0128] Figure A: In the horizontal axis: A: sample order: M: M1-M6; 1: M1(-); 2: M1(+); 3: M2(-); 4: M2(+); 5: M3(-); 6: M3(+); 7: M4(-); 8: M4(+); 9: M5(-); 10: M5(+); 11: M6(-); 12: M6(+); (-) is the negative control group, and (+) is the experimental group;
[0129] Figure B: In the horizontal axis: M, M1-M6; 1: control; 2: enzyme solution diluted 10 times and reacted for 10 seconds; 3-8: 10 seconds, 1 minute, 30 minutes, 3 hours, 12 hours, 48 hours;
[0130] Figure C: In the horizontal axis: M, M1-M6; 1, control; 2, enzyme solution diluted 10 times and reacted for 10 seconds; 3-5, 10 seconds, 1 minute, 48 hours.
[0131] The above-mentioned enzyme solution diluted 10 times and reacted for 10 seconds means that the enzyme solution prepared in Example 3 was diluted 10 times and then reacted for 10 seconds, and the rest means that the enzyme solution prepared in Example 3 was reacted for 10 seconds, 1 minute, 30 minutes, 3 hours, 12 hours, and 48 hours.
[0132] The results are as follows Fig.10 As shown, the recombinant β-mannanase rMan02066 described in the present application:
[0133] (1) Fig.10 (A) It can be seen that M3-M6 sugars can be degraded, but M2 and M1 cannot be degraded; when degrading M6 or M4, the final product is M2, and when degrading M5 or M3, the final products are M2 and M1;
[0134] (2) Fig.10 (B) It can be seen that when M5 is degraded, M3 & M2 are produced in a short time. As time goes by, M3 gradually degrades to produce M2 & M1.
[0135] (3) Fig.10 (C) It can be seen that when degrading M6, M4 & M2 are produced in a short time. As time goes by, M4 gradually degrades into M2, and the final main product is M2.
[0136] These results indicate that when the recombinant enzyme rMan02066 degrades manno-oligosaccharides: (1) the minimum substrate is M3 and the minimum product is M1; (2) when odd-numbered sugars are substrates, the final main products are M2 and M1; when even-numbered sugars are substrates, the final main product is M2; (3) when rMan02066 degrades manno-oligosaccharides, it is speculated that the disaccharide continuous exo-cleavage mode is used.
[0137] Example 13. Fluorescence-HPLC analysis of the cleavage pattern of recombinant β-mannanase rMan02066
[0138] Take a series of solutions containing 10 μg of manno-oligosaccharide (M-M6) and evaporate them separately. Add dimethyl sulfoxide (DMSO) solution containing excess o-aminobenzamide (2-AB) and sodium cyanoborohydride, mix well and incubate in a 60°C water bath for 2 hours. Evaporate to dryness, add deionized water to dissolve the sample, oscillate the sample with chloroform, centrifuge, and collect the supernatant. Continue to extract with chloroform repeatedly for no less than 7 times to obtain a series of substrate sugar chains, including mannohexose (2AB-M6), mannopentaose (2AB-M5), mannotetraose (2AB-M4), mannotriose (2AB-M3), mannobiose (2AB-M2), and mannose (2AB-M), whose reducing ends are labeled with 2-AB.
[0139] Take the above 2AB-M6, 2AB-M5, 2AB-M3, 2AB-M2, 2AB-M products, the dilution of the recombinant β-mannanase rMan02066 prepared in Example 3, 150mmol / L NaH2PO4-Na2HPO4 (pH7.0) buffer and water, mix them in a volume ratio of 2:1:3:4, and place them in a 40℃ water bath for reaction. Place the reaction system in a boiling water bath for 10 minutes, transfer to an ice water bath for 5 minutes, and centrifuge at 12,000×g and 4℃ for at least 15 minutes. Collect the supernatant. Perform a negative control reaction with the recombinant β-mannanase rMan02066 enzyme solution that was pre-heated in a boiling water bath for 10 minutes and then inactivated in an ice water bath for 10 minutes.
[0140] Use 0.20 mol / L NH4HCO3 solution to balance the Superdex TM 30Increase 10 / 300GL (GE, General Electric Company, USA) molecular gel chromatography column, flow rate 0.40mL / min, at least 2 column beds. The above fluorescently labeled series of manno-oligosaccharide samples with different enzymatic hydrolysis times were loaded with 20-200ng / sample by an automatic sampler, and other conditions remained unchanged, with an excitation wavelength of 330nm and an emission wavelength of 420nm for detection. The integrated area of each oligosaccharide component was analyzed using HPLC operating software, and the relative molar concentration was calculated in combination with the theoretical molecular weight.
[0141] The results are as follows Fig.11As shown in (A), it can be seen that when the recombinant enzyme rMan02066 degrades manno-oligosaccharides labeled with 2AB at the reducing end: (1) when degrading the even-numbered sugar chain substrates 2AB-M6 or 2AB-M4, the final product is mainly 2AB-M2&M2; (2) when degrading the odd-numbered sugar chain substrate 2AB-M5, the final product is mainly 2AB-M&M&M2; (3) when degrading 2AB-M3, the final product is mainly 2AB-M&M2; (4) the enzyme cannot degrade 2AB-M2 and 2AB-M; (5) In addition, the area integration method shows that when degrading 2AB-M4, the number of moles of 2AB-M2 produced is equal to the number of moles of the substrate sugar chain, while when degrading 2AB-M3, the number of moles of 2AB-M produced is equal to the number of moles of the substrate sugar chain.
[0142] like Fig.11 As shown in (B) and (C), the time gradient of the degradation of 2AB-M5 and 2AB-M6 by the recombinant enzyme rMan02066 is as follows: (1) When degrading the odd-numbered sugar chain substrate 2AB-M5, 2AB-M3 is produced in a short time, and 2AB-M3 gradually decreases with time, and finally 2AB-M is produced, and its area integral is equal to the area integral of the substrate sugar chain (i.e., the number of moles); (2) When degrading the even-numbered sugar chain substrate 2AB-M6, 2AB-M4 is produced in a short time, and 2AB-M4 gradually decreases with time, and finally 2AB-M2 is produced, and its area integral is equal to that of the substrate sugar chain (i.e., the number of moles is equal).
[0143] The above results show that when the recombinant enzyme rMan02066 degrades fluorescently labeled manno-oligosaccharides, (1) the minimum substrate is 2AB-M3 and the minimum product is M; (2) M2 is continuously cleaved from the non-reducing end of the substrate sugar chain substrate, and a disaccharide exo-cleavage pattern is exhibited; (3) when the final product containing the fluorescent label is 2AB-M2, the corresponding original substrate is an even-numbered sugar chain, and the molar number is equal to it; and when the final product containing the fluorescent label is 2AB-M1, the corresponding original substrate is an odd-numbered sugar chain, and the molar number is equal to it. Therefore, in theory, the enzyme or its recombinant enzyme can be used to analyze and determine the molar number of its original polysaccharide substrate sugar chain, that is, it can be used as a molar counter of the polysaccharide substrate, and can also determine the odd-even status of the original substrate.
[0144] Example 14. Multiple sequence alignment analysis of Man02066
[0145] The protein sequences of Man02066 and the identified GH26 family mannanases were aligned using DNAMAN software.
[0146] like Fig.12 As shown, the protein sequence of β-mannanase Man02066 (abbreviated as Man02066) is aligned with the protein sequence of mannanase of GH26 family:
[0147] (1) Blast P analysis showed that among the identified enzymes, Man02066 had the highest similarities with CjMan26A, CjMan26C, Mana-2, and Man26A, at 35.59%, 42.82%, 42.18%, and 35.15%, respectively;
[0148] (2) Multiple sequence alignment analysis using DNAMAN 8.0 revealed that the conserved catalytic site residue in the Man02066 sequence is Glu 188 (acid / base catalysis) and Glu 296 (Nucleophilic catalysis).
[0149] Example 15. Gene mutation of Man02066
[0150] The recombinant plasmid pET30a-Man02066 prepared in Example 3 was used as a template for PCR amplification. The amplification primers are shown in Table 1:
[0151] Table 1. Primers used for mutagenesis
[0152]
[0153]
[0154] The site-directed mutagenesis kit used was purchased from Nanjing Novozymes Biotechnology Co., Ltd. Site-directed mutagenesis was performed according to the experimental operation steps provided in the kit of this company. The obtained recombinant plasmids were sent to Sangon Biotech (Shanghai) Co., Ltd. for sequencing verification, and finally the correctly constructed recombinant plasmids pET30a-Man02066-E188A and pET30a-Man02066-E296A were obtained.
[0155] According to Example 3, the mutant recombinant plasmid was induced to express, the bacteria were ultrasonically disrupted, centrifuged, and the supernatant was transferred to obtain the crude enzyme solutions of the mutant recombinant enzymes E188A and E296A.
[0156] Example 17. Enzyme activity analysis of rMan02066 (abbreviated as Man02066) mutant
[0157] Prepare konjac glucomannan and locust bean gum substrates with a mass volume concentration (g / mL) of 0.3% with deionized water, heat to dissolve, and place in a 40°C and 50°C water bath environment to cool for 1 hour. Add 10-100 μL of the dilution of the mutant crude enzyme solution obtained in Example 16 to each 100 μL substrate. If the volume is less than 200 μL, add sterile deionized water, mix well, and continue to react for 12 hours. Heat the reaction product in a boiling water bath for 10 minutes, transfer to an ice water bath for 5 minutes, centrifuge at 12,000×g and 4°C for 15 minutes, and collect the supernatant.
[0158] The concentration of newly generated reducing sugar in each reaction system was determined by DNS-reducing sugar method (OD 540 ), and calculated the average value for deviation analysis. The control group was the maximum absorption value of the activity of the recombinant enzyme rMan02066 (set as 100%), and the relative enzyme activity (RA) was defined as the percentage of the absorption value of each mutant oligosaccharide product to the maximum absorption value.
[0159] Results A series of mutants of Man02066 showed poor performance in degradation of KGM ( Fig.13 A) and LBG( Fig.13 B), as shown in the figure: after the E188 and E296 residues were mutated, the enzyme mutants were all inactive, thus confirming that the two glutamic acid residues are the conserved catalytic site residues of Man02066.
[0160] All documents mentioned in the present invention are cited as references in this application, just as each document is cited as reference individually. In addition, it should be understood that after reading the above teachings of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the claims attached to this application. Sequence Listing Information: DTD version: V1_3 File name: P2020-1101.xml Software Name: WIPO Sequence Software version: 2.1.1 Date of creation: 2024-10-21 Basic Information: Current Applications / IP Offices: CN Current application / Application number: 202010525116 .2 Current application / Application date: 2020-06-10 Name of applicant: Green Valley (Shanghai) Pharmaceutical Technology Co., Ltd. Applicant's Name / Language: zh Applicant's name or title / Latin name: GREEN VALLEY (SHANGHAI) PHARMACEUTICALS CO.,LTD Inventor Name: Han Wenjun Inventor Name / Language: zh Inventor Name / Latin Name: HAN, Wenjun Invention Title: A disaccharide exo-cleaving β-mannan hydrolase and its application (zh) Total number of sequences: 8 sequence: Serial Number(ID): 1 Length: 1137 Molecule Type: DNA Feature Position / Qualifier: - source, 1..1137 > mol_type, genomic DNA > organism, Flammeovirga yaeyamensis Residue: atgagaaaga gattagtagc agcttctttt cttataggac ttctcacact aaactttgga 60 acagccgaag ataaggcaaa gacaccaaag ctaaatgata agaaagcaac gaaggagacg 120 gtagcattat acgagcaatt acatcaggtg agcgtaagtg gaaaaacaat ttttggacat 180 caagacgact tggctttatgg ataccattgg tggggcgatg gatcggatgt aaagaatgtg 240 acaggagatt accctggcct ttatggttgg gatatgggac atattggaga ggaaaaaaac 300 ttggatggtg ttcctttcga ggacatcaaa agatatatca aagagtcgta ttcgagagga 360 ggcattacca ctttgagttg gcacatgatc aatttaaaag aaaagagcag ttcttgggat 420 accacaagag tacttcatga aatgatggag ggaggtaagt atcaccaaga ctttattaaa 480 aagcttgact tgtttgccga atttgtggat gacctagaat tagaaggtaa gaaaattcca 540 gtattatta gaccatggca cgaacacaat ggttcatggt tttggtgggg aggaaagaat 600 gtggagatca aagattataa aactttgg caattcacag tggaatattt gagagataaa 660 aaggggattc ataacattat ctacgttat tctacagatg ccttcgattc ggaagaaagt 720 tatttagagc gttatcctgg cgacaaatat gtcgatgttt taggatttga tgattacggt 780 gcctaccgtg ctaacgctac tccagaaaga gaacaatgga ttataagaga attggaaacg 840 gtagccaaat tggcccaaca aaaaaataaa atctgtgcgt ttacagaatc tggtttggaa 900 gcagtgactg acgatcagtt ttttaccacc aagttattgg acaagctaaa tcacaatgaa 960 tggacaaaga aagccgctta tgtgatgctt tggagaaacg ccaactatca aaaagaacag 1020 agagatcatt tttatgcc ttacaaaggt cactcttctg ccaaagactt tatcaaattc 1080 aaagaagatc caagcattct ctttgagtct gatttgatga atatgaaagt gaattaa 1137 Serial Number(ID): 2 Length: 378 Molecular Type: AA Feature Position / Qualifier: - source, 1..378 > mol_type, protein > organism, Flammeovirga yaeyamensis Residue: MRKRLVAASF LIGLLTLNFG TAEDKAKTPK LNDKKATKET VALYEQLHQV SVSGKTIFGH 60 QDDLAYGYHW WGDGSDVKNV TGDYPGLYGW DMGHIGEEKN LDGVPFEDIK RYIKESYSRG 120 GITTLSWHMI NLKEKSSSWD TTRVLHEMME GGKYHQDFIK KLDLFAEFVD DLELEGKKIP 180 VLFRPWHEHN GSWFWWGGKN VEIKDYKTLW QFTVEYLRDK KGIHNIIYVY STDAFDSEES 240 YLERYPGDKY VDVLGFDDYG AYRANATPER EQWIIRELET VAKLAQQKNK ICAFTESGLE 300 AVTDDQFFTT KLLDKLNHNE WTKKAAYVML WRNANYQKEQ RDHFYVPYKG HSSAKDFIKF 360 KEDPSILFES DLMNMKVN 378 Serial Number(ID): 3 Length: 29 Molecule Type: DNA Feature Position / Qualifier: - source, 1..29 > mol_type, other DNA > organism, synthetic construct Residue: gcgcatatgg aagataaggc aaagacacc 29 Serial Number(ID): 4 Length: 33 Molecule Type: DNA Feature Position / Qualifier: - source, 1..33 > mol_type, other DNA > organism, synthetic construct Residue: gcgctcgaga ttcactttca tattcatcaa atc 33 Serial Number(ID): 5 Length: 33 Molecule Type: DNA Feature Position / Qualifier: - source, 1..33 > mol_type, other DNA > organism, synthetic construct Residue: atggcacgca cacaatggtt catggttttg gtg 33 Serial Number(ID): 6 Length: 34 Molecule Type: DNA Feature Position / Qualifier: - source, 1..34 > mol_type, other DNA > organism, synthetic construct Residue: cattgtgtgc gtgccatggt ctaaataata ctgg 34 Serial Number(ID): 7 Length: 33 Molecule Type: DNA Feature Position / Qualifier: - source, 1..33 > mol_type, other DNA > organism, synthetic construct Residue: cgtttacagc atctggtttg gaagcagtga ctg 33 Serial Number(ID): 8 Length: 36 Molecular Type: AA Feature Position / Qualifier: - source, 1..36 > mol_type, protein > organism, synthetic construct Residue: ACCAGATGCT GTAAACGCAC AGATTTTATTTTTTTG 36 END
Claims
1. A mutant of an exo-acting β-mannanase, characterized in that: The amino acid sequence of the exo-β-mannanase is shown in SEQ ID NO: 2, wherein the exo-β-mannanase has a mutation at amino acid position 188 or 296; In the amino acid sequence of the exo-type β-mannanase, the 188th amino acid is mutated from glutamic acid to alanine, or the 296th amino acid is mutated from glutamic acid to alanine.
2. Use of the mutant of the exo-acting β-mannanase according to claim 1 as a tool enzyme in studying the catalytic mechanism of mannanase.
